Home › Markets › Health Care › TVRD

Tvardi Therapeutics Inc. (TVRD)

TVRD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.04
-1.89% on the day
Market cap
$13.9M
Nano cap
Revenue · 2024
$7.1M
-66.0% on 2023
Net income · 2024
-$29.4M
-411.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.

Profile

FieldValue
TickerTVRD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2014
SEC CIK0001346830
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2024

LineValue
Revenue$7.1M
Net income-$29.4M
Operating income-$28.1M
Net margin-411.9%
Operating margin-393.8%
Revenue growth-66.0%
Cash$31.6M
Total assets$35.2M
P/E (computed)Net income was not positive
P/S (computed)1.9×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-17
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-14
Latest current report
FORM 8-K
8-K2026-08-14
Latest proxyDEFA14A2026-04-23

Source: SEC EDGAR submissions feed, 809 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ALLRAllarity Therapeutics Inc.$0.8699+1.14%$13.8M
HINDVyome Holdings Inc.$1.97-1.99%$13.8M
KTTAPasithea Therapeutics Corp.$0.4238-5.30%$14.2M
RKTORocket One Inc.$0.5708-4.85%$14.2M
GTBPGT Biopharma Inc.$6.50-4.41%$13.4M
LPCNLipocine Inc.$1.62-2.41%$13.4M
BFRIBiofrontera Inc.$0.8922-3.56%$13.3M
PTNPalatin Technologies Inc.$8.19-4.21%$14.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier